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Ethical Considerations for Neuropsychologists as Functional Magnetic Imagers
Abstract
This discussion highlights ethical and practical issues potential neuropsychologist-imagers should
consider in conducting functional magnetic resonance imaging (fMRI). While fMRI is not currently
approved for clinical use, research is ongoing which has implications for clinical practice, from refining
brain–behavior relationships, to assisting with diagnosis and treatment decisions. To protect the welfare
of cognitively impaired populations requires special care with respect to MR risks and informed consent.
Competent functional imaging requires an understanding of the strengths, limitations, and appropriate
domain of applications of the measure.
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1. Introduction
Functional MRI (fMRI) has great potential to enhance the characterization of brain
integrity in people with cognitive dysfunction; hence, neuropsychologists have joined the
rush to use this technology. This fact was strikingly evident at the 2002 International
Neuropsychology Society meetings where 60 percent of the symposia revolved around
brain imaging. Functional MRI is becoming more widely applied in part because it is
noninvasive, can be performed in sites with clinical MRI’s, and there are easily available,
affordable, analysis tools. While fMRI is not yet approved for clinical use, techniques are
being tested and validated which have the potential to become part of the tools of the
neuropsychologist. Guidelines for use must thus follow both from the specific constraints
of the MRI technology and the domains of appropriate application. While detailed
descriptions of guidelines for the ethical and competent practice of clinical
neuropsychology, psychological assessment, and test use have been described (American
Academy of Neurology, 1996; American Psychological Association, 1992; Turner,
DeMers, Fox, & Reed, 2001), these do not adequately cover the specific requirements
and potential applications presented by fMRI. Below are suggested revisions of these
standards.
The focus of this paper will be on aspirational goals for the manner in which fMRI data
may be ethically applied to the practice of clinical neuropsychology; however, many of
the recommendations are relevant to all fMRI users. The first section discusses informed
consent for the procedure and risks. The second section outlines a series of core
competences. For example, fMRI imagers must understand the kinds of questions that
can be interrogated with the technique and they must cope with threats to validity,
limitations on generalizability, and avoid analysis and interpretive errors. The final
section briefly discusses examples of clinical applications and related ethical problems.

2. Informed consent, competence, and protection from
harm
There are several protections for patients with cognitive impairments who participate in
medical research. These issues are discussed in more detail elsewhere (Dunn &
Chadwick, 1999) but will be briefly summarized below. The right of individuals to

choose what will happen to them would likely prevail in a situation, such as deciding not
to perform functional imaging, where there is no clear benefit from undergoing the
procedure ( National Commission for the Protection of Human Subjects of Biomedical &
Behavioral Research, 1979). Even when there are approved clinical uses, the level of
benefit to the patient and the existence of alternative procedures to address the clinical
needs must be weighed against the risks of the procedure. Under no circumstances should
anyone be allowed to participate in an fMRI study if there are significant safety concerns,
even if they acknowledge and wish to participate in spite of the risks. During the process
of obtaining informed consent, participants need to be provided with adequate
information regarding planned procedures which they must comprehend and voluntarily
agree to without undue coercion (for a clear discussion see Dunn et al., 1999; National
Commission for the Protection of Human Subjects of Biomedical & Behavioral Research,
1978; NBAC, 1998). Information typically important to include are the specific benefits
to the individual or to patient care in general, risks, right to withdraw from participation,
and to have questions answered. Procedures must be adapted to patients to compensate
for cognitive deficits that interfere with comprehension, requests for information, or
memory for information that would affect the patient’s willingness to participate. A
signature on a consent form is evidence that this process was completed successfully.
There are some special issues to consider with respect to informed consent and the MRI
environment. In informing patients of potential risks, it is important for an imager to
assess each patient carefully with respect to their risk in the MRI environment and to
consult more expert colleagues, typically clinical radiologists, when there is any
uncertainty. The most dangerous risks are from ferromagnetic objects which become
projectiles in the strong magnetic field of the MR scanner, and from implanted
electromechanical devices, such as pacemakers, that cannot function in the magnetic
field. Sometimes a neuroradiologist will request an X-ray as part of a safety evaluation
and patients must also provide informed consent for this procedure. When there is a
question as to whether a patient is an accurate reporter of his medical history due to
cognitive impairments, at a minimum, special precautions such as a medical record
review or a careful interview with a spouse should be instituted. Shellock offers
comprehensive reference materials on the subject both in published form (Shellock, 2001;
Shellock, 2002) and on-line (www.mrisafety.com). Great caution should be exercised
when studying people from certain occupations, particularly those involving grinding
metal. If there is any concern that metal flakes entered the eyes, they should not be
studied unless there is a compelling clinical need, and then only after a special workup
(e.g., X-ray).
Other typical safety issues include the necessity for all people, including any caregiver
accompanying the patient in the MRI room, to wear MR compatible earplugs to dampen
noise. There is also the potential for sensory stimulation, minor muscle twitches,
particularly at higher field strengths than the standard clinical 1.5 Tesla MRI. There are
no known residual health problems that result from these symptoms. Scanning
claustrophobic people is problematic since the MRI environment is confining. Most
people with claustrophobia will warn the investigator and probably choose to avoid the
study, in which case of course they should neither be coerced nor even cajoled. Quite a

few individuals with claustrophobia, however, even among those who volunteer as
healthy participants, are unaware of their condition or decide to try to overcome it by
forcing themselves into anxiety provoking situations. A good practice is to warn every
potential participant. An example of such a warning might be "We previously asked you
if you were uncomfortable in confined places such as elevators. Most of us are a little
nervous the first time we undergo an MRI; however, occasionally people are surprised by
how anxious they become and would like to end the study. Please tell us immediately if
this is the case by pressing this alarm button and we will stop everything and promptly
pull you out of the MRI." Participants typically need a great deal of reassurance and
support if this occurs. Commonly participants fear disappointing the investigator or that
they have a newly discovered anxiety disorder. Stressing that nervousness is natural and
that "toughing it out" despite extreme anxiety invalidates the study often facilitates
admissions of reluctance to continue participation.
With respect to confidentiality, investigators in the behavioral sciences, where some
disorders are still stigmatized, should be particularly vigilant with respect to whether their
image files contain information that can identify patients. While there are no procedures
available to identify uniquely someone on the basis of a picture of their brain, some
image formats contain names if they were entered during data acquisition. It is possible to
strip this information from the image files, however. This must be done if an investigator
plans to provide data to larger databases such as the Neuroimaging Informatics
Technology Initiative, or contribute to journals where there is the requirement to provide
raw data (e.g., Journal of Cognitive Neuroscience). Several participants enter studies
because they expect that their images will be reviewed by a physician. It is prudent to
inform the participant whether or not this is the case during informed consent and to have
in place a protocol for consulting with competent neuroradiologists in a situation where
pathology is suspected. It is better yet to include a neuroradiologist who will routinely
inspect the images and perform a "clinical reading" to the limited extent feasible from the
structural component of the fMRI study. Regardless, it would be prudent to inform the
participant that the fMRI procedure is not designed to screen for brain disorders and that
if they suspect a problem they should consult a neurologist for referral to a clinical study.
Of course, neuropsychologists are not competent to practice neuroradiology and need to
inform participants about this limitation. If neuropsychologists detect an abnormality on
an MRI scan, they should consult a neuroradiologist to decide whether a clinical referral
should be made. Ethical issues associated with such incidental findings are discussed
elsewhere (Illes, Desmond, Huang, Raffin, & Atlas, 2002; Kulynych, 2002).
Like other clinical investigators, functional imagers may confront situations where
decisions must be carefully made as to whether a patient is competent to consent to
undergo functional imaging. Obtaining informed consent from the cognitively intact
participants themselves is the rule, but questions of competence to consent may arise with
several populations such as children, retarded individuals, people with certain
neuropsychiatric disorders or otherwise cognitively impaired patients. If there is a
question as to whether the patient is capable of formal informed consent, it is possible to
include a surrogate or proxy decision maker and to obtain the patient’s assent. A person is
capable of assent if they know the procedures they will undergo, unambiguously

communicate this willingness to participate, and understand their right to withdraw from
participation at any time (National Commission for the Protection of Human Subjects of
Biomedical & Behavioral Research, 1978). Establishing that the patient can provide a
reliable yes-no response is crucial (e.g., asking redundant questions with different
responses "Do you want to stop? Do you want to continue?"). It is the recommendation of
the National Bioethics Advisory Commission ( NBAC, 2001) that assent alone is not
sufficient to enroll a patient in a research protocol. The role of the proxy decision maker
is to advise the investigator how the patient would have decided had he or she been
cognitively capable. This topic is reviewed in depth elsewhere (Dunn et al., 1999; NBAC,
1998; NBAC, 2001).
The MRI environment imposes particular difficulties for investigators in monitoring
patient’s continued willingness to participate. Patients lie in the MRI so that many cues
about their emotional status, such as their facial expressions, are not observable. It is thus
crucial to assess carefully whether it is possible, and what kind of support patients need in
order to remain motivated and oriented to the task at hand. For example, patients with
severe memory disorders need to be repeatedly monitored since they are vulnerable to
disorientation. Furthermore, it is important to be vigilant for cues that indicate the
patient’s willingness to continue has changed. For example, some patients are surprised
to discover they have become claustrophobic in the MRI environment and might begin to
try to escape from a head positioning device. It is advisable to agree ahead of time on a
signal for distress, but it may be necessary to incorporate breaks and ask through the
intercom or headphones whether the participant feels comfortable continuing the study.

3. General core competence in the use of fMRI
measures
Most neuropsychological practice and potential applications of fMRI fall within the
domain of assessment. Given the costs of using the MRI, fMRI is not likely to be used
directly in therapy in the near future. Guidelines for test user qualifications for
psychologists specify necessary general and domain specific knowledge and skills
(Turner et al., 2001). This section focuses on general problems with which an fMRI user
must cope. The next section will briefly outline examples of clinical translations and the
manner in which ethical issues are relevant.
Current ethical guidelines dictate that psychologists not practice outside limits of their
education, training, and experience. Because there are no FDA approved clinical uses for
fMRI, credentials and training requirements have not been established. This situation will
likely change as clinical applications are tested and validated (for excellent reviews on
fMRI task design, see Aguirre & D’Esposito, 2000; Donaldson & Buckner, 2002; Miezin,
Maccotta, Ollinger, Petersen, & Buckner, 2000). There are minimal and crucial skills to
be acquired and knowledge that must be learned to assure valid fMRI results and these
are not formally taught to psychologists as part of their training. Until there are
significant technical advances, the burden is on the fMRI user to avoid confusing the
scientific community with erroneous interpretations of artifacts. Below, there is a brief

description of some of the major threats to valid fMRI results. For more detail, Thulborn
and Gisbert (2002) provide a readable description of what is involved in actually
acquiring fMRI data in a clinical setting.

3.1. Selection and design of appropriate tests
A central area of competence for developers of fMRI paradigms is understanding what
questions can be addressed with the method, and keeping pace with advances in task
design. Brain imaging studies are uninterpretable unless carefully designed and applied.
It is tempting to create imaginative experiments that try to address clinically relevant
questions directly such as "which brain structures underlie driving competence?", and to
have patients performing simulated driving evaluations in an fMRI study. These studies
of complex tasks will essentially activate the entire brain. For example, visual cortex will
be activated by looking at the road, and motor cortex will become active when one turns
a steering wheel. Neither of these findings is likely to yield anything surprising or
distinctive about driving. Ultimately, one would need to establish predictive or criterion
validity, in this case, predicting driving accidents. Unless the external event occurs
frequently, one would need to image many people to have a large enough sample to
establish a correlation. In part, because of the expense of imaging, these studies are
difficult to perform. For these reasons, it is hard, but not necessarily impossible, to apply
functional imaging in a manner that would justify making specific recommendations
about complex tasks such as a given functional capacity. As with other
neuropsychological tests, a functional imaging evaluation would need to be interpreted in
a larger context of a comprehensive cognitive evaluation.
In contrast, the underlying construct of a well-designed brain imaging paradigm is
typically the definition of a single or network of brain structures subserving a specific
cognitive process (e.g., Gur, Erwin, & Gur, 1992). Because fMRI analyses involve
thousands of statistical comparisons (leading to a high likelihood of false positive
results), an imager must have some a priori hypothesis about which specific brain
structures are likely to be activated by the cognitive task. Hypotheses typically are
developed from lesion studies in humans and animals, or from recordings from single
neurons in which the human or animal is performing a behavior. While all tests must be
interpreted within the context of a more comprehensive evaluation, fMRI is likely to be
most valuable in situations where clinical decision making hinges on a limited number of
brain functional systems.
In this context it is important to remember that many of the functional imaging studies
performed hitherto included small samples and their effects may have limited
applicability to individual cases. Without better knowledge of how many individual
participants are expected to show an effect, it is hazardous to conclude about an
individual that the pattern of activation is "abnormal." It will take the field a while to
assemble the kind of "normative" data that would permit individual assessments. The
ethical neuropsychologist will be careful to avoid inappropriate and premature use of the
power of fMRI to show effects that to a layman may seem conclusive but that in reality
may reflect dubious procedures or interpretations. Nonetheless, the power of the method

will eventually bring it to the clinical arena and those neuropsychologists who learn how
to use fMRI competently and carefully will be poised to exploit its immense potential for
assessment of disease and treatment effects.
An example of how an fMRI finding can lead to pressures for premature application is
recent studies showing the ability of fMRI to detect deception (Langleben et al., 2002).
Attorneys, judges, and law enforcement agencies rushed to try and use fMRI for lie
detection, not realizing that the effects were demonstrated on group data and the road is
long before the method can be justified for identifying individual deceivers, let alone
specific items in which deception has occurred. It is an ethical obligation of a
neuropsychologist to explain these limitations to potential clients who may want to use
the study in litigation or law enforcement.

3.2. Sources of error variance
3.2.1. Artifacts from acquisition and individual differences in the MRI signal
A competent fMRI user is vigilant and aware of how to cope with acquisition artifacts, a
major threat to the validity of imaging results. There are known artifacts at the level of
image acquisition, such as signal loss (appearing as dark regions called susceptibility
artifact). They are problematic in regions where tissue characteristics change abruptly,
such as near air passages. Susceptibility artifacts abound near the orbitofrontal/anteriormedial temporal region of the brain. Other artifacts include movement artifacts, field
inhomogeneity effects ("shading"), physiological artifacts related to heart rate and
breathing, anatomic distortions and other causes of instability of the fMRI signal. There
are techniques under development such as "on-line" movement correction, acquiring
separate images within the susceptibility region, and compensating for image distortions.
Until corrections or detection algorithms become routine, imagers must be able to
recognize these problems and determine in each patient whether they can be ameliorated
through post-processing or careful interpretation.
Aside from artifacts within an individual scan, fMRI researchers must be aware that there
are differences across individuals and MRI sites, and scanner "drifts" within the same
facility even within a single session, which introduce artifacts and error. Even if one
follows the exact same imaging protocol, the MRI signal differs across individuals
(Aguirre, Zarahn, & D’Esposito, 1998; Buckner, Snyder, Sanders, Raichle, & Morris,
2000; D’Esposito, Zarahn, Aguirre, & Rypma, 1999). Statistical comparisons across
different patient groups must take into account these individual differences. MRI
manufacturers, and upgrades of the same manufacturer, may change the image quality of
the MRI so there must be user intervention to test and compensate for changes in
parameters such as image contrast and field homogeneity. Methods of testing
comparability of data across different sites are under development for structural (e.g.,
Styner, Charles, Park, & Gerig, 2002) and functional (G. Glover, personal
communication) imaging protocols. The process typically involves scanning a phantom
or relatively stable test subject (e.g., a person without a progressive dementia or a

developing brain) at several MRI sites and analyzing the inter- and intra-site stability of
the measure of interest.
Functional MRI investigators must also be familiar with artifacts that constrain processes
that can be studied. For example, tasks that require overt verbal responses are not often
studied with fMRI because of the associated head movement and susceptibility artifact
from changes in the vocal cavity. In addition, it is difficult for the participant to hear
auditory stimuli, or for the investigator to hear responses over the noise of the MRI,
without special equipment. Some cognitive tasks that are part of a standard cognitive
evaluation, such as confrontation naming, verbal fluency, and memory recall are thus
problematic to study with fMRI. There are specialized image processing techniques to
compensate for talking-related artifact in the MRI (e.g., Birn, Bandettini, Cox, & Shaker,
1999), however, the burden is on the imager to demonstrate that activation is not
artifactual.
3.2.2. Inappropriate controls
Functional MRI depends on differences between conditions and hence the choice of
comparison tasks affects the sensitivity of the measure. Activation and control conditions
are carefully matched for motor and sensory stimulation, as well as other hypothesized
confounding cognitive processes. Often, a resting baseline (control) or a less carefully
matched condition is included. The choice of baseline condition has been a subject of
controversy (e.g., Stark & Squire, 2001) since, for example, if participants continue to
rehearse mentally the experimental task, the difference in activation between task-on and
task-off will be reduced. Ultimately, a competent imager must be familiar with the
opinions in the field and able to defend how well the choice of comparison tasks controls
for activations that are unrelated to the domain of interest.
3.2.3. Standardized administration procedures
While the standardized neuropsychological assessment rigidly adheres to carefully
worded scripts and particular stimulus materials, and hence neuropsychologists are well
trained in rigorous testing procedures, fMRI has additional requirements. Several of the
problems of selecting appropriate control conditions are similar to those involved in
standardization since one goal involves minimizing task-irrelevant brain activation.
Imagers are responsible for monitoring the literature on processes invoked during
imaging (e.g., sensory, motor, and rest) to increase the chance that appropriate
standardization procedures will be instituted. For example, failure to standardize image
contrast and visual angle generally has only subtle effects on neuropsychological tests.
Variability in these and other perceptual and movement parameters has a large impact on
brain activity because of differences such as amount of stimulation to visual cortex, eye
movements, and spread of attention to the periphery. There are attempts to standardize
the stimulus display and behavioral measurements in fMRI (e.g., Integrated Functional
Imaging System, MRI Devices, Waukesha, WI); however, the costs are high and
development is complex since MRI manufacturers build different sized MRI’s and
stimulation paradigms vary considerably in their requirements.

3.2.4. Characteristics of the test takers and generalizability
Functional MRI users must be vigilant for motivational, cognitive, and functional
disabilities which interfere with valid test performance. Not only is it unethical to
perform fMRI on an unwilling patient, in most situations it is nearly impossible to obtain
valid results. In some analyses, a head movement of greater than 2 mm over the course of
a minute or an hour will render data useless. Investigators should aim to obtain on-line
performance data and at least intermittently monitor the accuracy of behavioral responses
during MRI scanning (typically there is a signal in the control room to the investigator,
indicating the participant’s response). Such monitoring is needed to confirm that patients
have not lost the instructional set or are responding intermittently. Paradigms that do not
collect any measure of accuracy are problematic since one cannot be certain that patients
are performing the desired cognitive operations.
Certain aspects of the MRI environment make a task more cognitively complex than an
evaluation outside the MRI. These nonspecific environmental effects may interact with
certain forms of cognitive dysfunction. In addition to the constraints of the small space
and complicated interaction between participant and investigator, there is a loud,
distracting, radiofrequency pulse. Patients must often be able to remember and shift
between different cognitive tasks based on cues or instructions given before the imaging
task begins. Patients with severe memory or executive dysfunction may have difficulty
remaining oriented or controlling the impulse to move. Patients may even fall asleep. All
of these cognitive and motivational issues must be considered in interpreting data
collected on patients in the MRI environment.
Clinical assessments require compensation for disabilities that affect the validity of the
measure; however, once the patient enters the MRI environment, changes to the paradigm
in individual patients are ill advised unless the change in concomitant brain activity is
part of the study. Furthermore, all items placed in the MRI environment have the
potential for either producing artifact or being safety risks. For example hearing aids
cannot be used. Acuity correction is not simple since most eye glasses contain metal and
specially designed glasses need to be used. Sometimes investigators have every
participant wear glasses, some with no correction, so that the periphery of the visual field
is occluded equally in all participants.
These practical and ethical problems, and difficulties with scanning unwilling or
cognitively impaired patients, limit the population of patients that can undergo fMRI and
hence the generalizability of findings. Essentially, fMRI will likely be restricted to mildly
impaired patients until there are significant changes to the testing environment. This must
be considered when one attempts to extrapolate findings to more cognitively and
functionally impaired groups.
3.2.5. Reliability and sensitivity
A competent fMRI user is familiar with the particular statistical problems fMRI data
raise; however, fMRI research is only beginning to address the quantification of

reliability and measurement error. Imaging patients introduces another layer to this
complex problem. New acquisition, experimental designs, and statistical analyses will
likely be developed and optimized to address such concerns. Approaches to setting
statistical thresholds are still heatedly debated in fMRI. Part of the reason is that task
design markedly affects the sensitivity to activation. For example, an fMRI study that
attempts to measure individual events (event-related fMRI) may demonstrate less robust
results than one in which several events are averaged in a blocked design. On the other
hand, event related fMRI could be particularly useful when comparing patients and
controls since one can select only accurate trials across the groups (provided that the
design has enough power for such an evaluation) and thus be more certain that the
cognitive processes underlying the functional effects are similar. One could increase the
number of trials to compensate for having a weaker ability to detect activation but then
validity can be compromised by the ability of participants to tolerate the environment for
a long period of time. Nonetheless, it is encouraging that studies examining reliability of
fMRI results across different sites and within individuals have yielded promising results
(Aguirre et al., 1998; Casey et al., 1998; Cohen & DuBois, 1999; Machielsen, Rombouts,
Barkhof, Scheltens, & Witter, 2000; Ojemann et al., 1998; Rombouts, Barkhof,
Hoogenraad, Sprenger, & Scheltens, 1998). The number of tasks in which reliability has
been described, however, is quite small at present.

3.3. Interpretation of results
Conclusions about the role of a particular brain region in a cognitive process should be
based on a convergence of information, not a given fMRI experiment. Functional MRI
results are merely a statistical representation of a relationship between temporal changes
in a cognitive task and recruitment of blood flow to a brain region. This co-occurrence
does not definitively demonstrate that a brain region is involved in a task, only that the
region may be active during the task. Even then, blood flow is only an indirect measure
of neuronal activity. Because functional activation is defined based on statistical
significance, failure to activate is a statistical null effect and should also be interpreted
with great caution mindful of Type II error. Inappropriate control conditions and any of
the above-described artifacts can reduce the chance of detecting an fMRI result or yield
spurious findings. Neuropsychologists can provide crucial complimentary information to
fMRI data as they are likely to be familiar with research demonstrating relationships
between lesions and cognitive deficits that may suggest that the damaged area is
necessary or provides connections to regions crucial for performance of a task.
Performing fMRI on patients with brain dysfunction provides clues to the process of
functional reorganization when effectiveness of recovery is associated with particular
patterns of activation (e.g., Horwitz, Rumsey, & Donohue, 1998; Maguire, VarghaKhadem, & Mishkin, 2001).

3.4. Consultation with colleagues and institutional support
Because techniques are evolving quickly, it is recommended that anyone using fMRI in a
program of research have significant institutional and expert collegial support. For
example, sites should include a staff MR physicist who assures that the scanner performs

to specifications and that data acquisition is maximally sensitive to functional activation.
A physicist is also likely to understand and be familiar with artifacts that can disrupt
image quality. Just as current, validated and sensitive tests should be used in the
neuropsychological evaluation, there must be institutional support and adequate resources
to pay for the MRI infrastructure, including software and hardware upgrades to MRI
scanners. Special MR compatible equipment is needed for displaying stimuli and
collecting behavioral data in the MRI and this poses difficult challenges. Sites should
have access to engineers and machinists to develop and maintain such devices. Even
experienced MR technicians need to be trained to avoid various artifacts that may distort
the fMRI signal. For example, fMRI data are particularly vulnerable to artifacts from
certain dental work or medications that affect blood flow and these are less of a problem
for standard pulse sequences used in structural imaging for clinical purposes. Many sites
have "image processors," people dedicated exclusively to image analysis and software
development. Most investigators performing functional neuroimaging also obtain advice
from software developers through on-line list servers. An imager must be competent to
understand and evaluate the accuracy of this advice. This usually involves learning new
approaches to statistical modeling and image processing and vigilant monitoring of new
analysis techniques. Developers of research-dedicated image analysis products (e.g.,
AFNI, Statistical Parametric Mapping) recommend against clinical application because
the source code is written by multiple users in the community and thus it is nearly
impossible to guarantee it as error free. In its current implementation this software is far
from "fool proof" and indeed not very "user friendly." Translating a paradigm from an
experimental to a clinical application to be administered in multiple sites, as is done with
neuropsychological tests, therefore requires much careful pre-testing and possibly
debugging of computer code.

4. Approaches to clinical translation
There are several approaches the neuropsychologist might take to using data from fMRI.
Potential clinical applications of fMRI are reviewed in more depth elsewhere (Detre &
Floyd, 2001; Hammeke, 2002; Stern & Silbersweig, 2001; Thulborn et al., 2002). Ethical
problems and dilemmas are omnipresent when translating research to clinical
applications. In general, the more autonomy and flexibility fMRI users have, the greater
the potential for error. Developing fMRI paradigms for potential clinical use in individual
patients requires the highest level of skill and competence. Some day, there will likely be
clinical protocols where both acquisition parameters and analyses have been well
worked-out and established as valid and reliable across sites. Until such technical
advances are achieved, fMRI users will still need to assess data quality and upgrade
equipment and software. However, there will be less of a demand to innovate, as has been
the case with the traditional clinical neuropsychological examination. Another approach
to clinical application is using fMRI to validate other measures or techniques. For
example, rather than applying fMRI to individual patients, one could study a subgroup of
controls and validate new neuropsychological tests as indicators of the integrity of a
particular brain system. Alternatively, one might use fMRI as a marker of drug treatment
response in a patient group. In this form of clinical research, the burden on the researcher
is to describe limitations to interpretation and generalizability. For example, careful

description of the patients tested and methods by which areas of activation are defined is
crucial for describing the manner in which a paradigm is applied. For instance, some
investigators limit the number of statistical comparisons by a priori definition of a small
brain region on the basis of structural landmarks. Some investigators interrogate a small,
functionally defined, region of interest (e.g., using retinotopic mapping) before beginning
a study. Most investigators perform analyses on the entire brain. Each of these
approaches affects statistical power tremendously.

4.1. Applications and ethical dilemmas
Functional imaging may provide information about brain localization in individual
patients that is unavailable with other technologies. For example, there is hope that fMRI
can reveal islands of functional sparing within, and subtle functional decrements outside
of lesions that are only grossly apparent on MRI scans. Interpreting lesion-function
relations is confounded by the fact that there is functional reorganization after brain
damage. Defining regions of brain activation with fMRI in individuals rather than on the
basis of group studies further refines localization information. The fMRI study can
describe the neural substrates of component processes of which behavioral
neuropsychological tests detect only the result. For example, event related fMRI has not
only separated the functional activation related to encoding from retrieval, but has also
demonstrated differences in the same person in brain functioning during encoding of
items that were remembered versus those that were forgotten (Brewer, Zhao, Desmond,
Glover, & Gabrieli, 1998; Wagner et al., 1998). There are several important potential
clinical fMRI applications that follow from these advantages.
In neurosurgical interventions, accurate localization is critical and treatment risks are
high. In the case of tumor removal or medial temporal lobe resection for seizure control,
outcome can be improved (i.e., halting tissue destruction from invasive pathology or
seizure control) as larger tissue volumes are removed; however, this must be balanced
against the risk of damaging adjacent functionally active tissue. Localization errors can
lead to significant disability and thus this application presents one of the highest levels of
risk. Functional MRI can be applied to help the neurosurgeon walk this tightrope by
identifying regions where there may be a greater risk of deficit following removal. Such
paradigms can provide convergent data complementing information obtained by
temporary inactivation techniques (e.g., Wada, TMS, or cortical stimulation during
neurosurgery). Given the current state of technology, using fMRI alone without
inactivation techniques is problematic.
Just as structural imaging is central to the diagnosis of tumors and strokes, functional
imaging is being tested as a potential method to improve the quality of diagnosis where a
specific distribution of brain functional pathology is expected but difficult to detect with
existing technologies. For example, various types of lesions within the medial temporal
lobe (MTL) may disrupt memory; however, differences in functional activity across
different MTL subregions may differentiate older adults who have Alzheimer’s disease
(AD) pathology from other disorders (e.g., Small, Perera, DeLaPaz, Mayeux, & Stern,

1999). The risk of misdiagnosis to the patient is significant, but more harmful if the result
is delay or denial of effective treatment.
Functional imaging may assist in demonstrating the brain regions being affected by drug
treatment (e.g., Rombouts, Barkhof, van Meel, & Scheltens, 2002; Sperling et al., 2002),
functional compensation (e.g., Horwitz et al., 1998; Maguire et al., 2001), and disease
progression. It is possible that different patterns of brain activation could be associated
with similar behavior in the present, but different responses to psychological and
pharmacological treatments. Functional MRI is thus under development as a marker of
treatment response. Errors could result in denial of effective treatment while appropriate
use may lead to a more cost effective distribution of limited resources. Some fMRI
approaches could be applied to define subgroups at-risk for the development of brain
disease. Clinical trials performed on at-risk subgroups typically require fewer participants
(due to less intersubject variability of response); however, this limits the generalizability
to these populations and thus may result in treatment guidelines that restrict access of
other groups. Ultimately fMRI is an expensive technology and appropriate use must take
into account the manner in which results complement and augment information already
available about the function of healthy and impaired brains.

5. General conclusions
Functional imaging, if applied responsibly, has great potential to enhance
neuropsychological assessment and to be a useful component of a comprehensive
evaluation in certain conditions. Because the technique reveals new information about the
brain, it is essential to consider its limitations. Perhaps most importantly, current
implementations of fMRI only have the power to answer a few questions at a time.
Therefore, fMRI should only be used in a given patient in the context of a broader
cognitive and clinical evaluation. Competent use of fMRI requires an understanding of
when imaging applications are appropriate. Furthermore, acquisition, analysis, and
interpretation of imaging results must be informed by an acute awareness of the technical
characteristics and limitations of the measure (e.g., Jezzard, Matthews, & Smith, 2002;
Moonen & Bandettini, 1999; Toga & Mazziotta, 2000). There are multiple practical
hurdles to performing fMRI research. Obtaining informed consent in a cognitively
impaired population is more complex than in the standard neuropsychological context. In
addition, the risks to participants are higher than in traditional neuropsychological
procedures. With careful screening and safety procedures, the long term effects of
exposure to the magnetic field are believed to be negligible; however, emotional and
physical responses to the stress of prolonged immobility and confined environment must
be considered when testing cognitively and emotionally disabled individuals. For now,
performing competent brain imaging requires intensive time commitment and
institutional support. In addition, much work is needed before current brain imaging tools
have the psychometric rigor to be applied to the clinical evaluation of individual patients.
It is an ethical responsibility for a neuropsychologist involved with fMRI to recognize the
current state of knowledge and the extent to which it justifies procedures and conclusions
applied to individuals. The ethical neuropsychologist will resist pressures to make
premature interpretations, particularly when the audience is not qualified to evaluate their

factual basis. While these techniques are relatively young, they are rapidly maturing and
will likely revolutionize the field of clinical neuropsychology by illuminating aspects of
brain–behavior relationships that were previously inaccessible. The neuropsychologist
who will enter the field now will be in a position to work at the forefront of an exciting
new field, which at some point will be recognized as a legitimate subspecialty of
neuropsychology.
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